Clinical Trial Update: Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial from MD Anderson is evaluating a combination therapy to treat sleep disturbance in patients with advanced cancer. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Combination therapy (not disclosed)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Sleep, Fatigue | Phase 2, Phase 3 | Status: RECRUITING